title: Stroke risk reduction: focus of the new ESC guidelines.
authors.forename: J
authors.initials: J
authors.lastname: Aalbers
mesh_terms: D000991:Antithrombins / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran